RCE ASX Chart
Snapshot
Recce Pharmaceuticals Ltd (RCE) is a drug discovery business engaged in development of new class of Synthetic Anti-Infectives designed to address the global health problems of antibiotic-resistant superbugs and emerging viral pathogens. Recce's anti-infective pipeline includes three patented, broad-spectrum, synthetic polymer anti-infectives: RECCE 327, RECCE 435 and RECCE 529.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2023 YTD | |
1 Year | |
vs Sector (1yr) | -22.66% |
vs ASX 200 (1yr) | -29.41% |
Top Market Index News
Announcements
Corporate Overview
Corporate Details
Head Office | Sydney NSW 2000 |
Website | www.recce.com.au |
Registry | Automic Group |
Auditor | BDO Audit (WA) Pty Ltd |
Date Listed | 15 Jan 2016 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
26/02/2024 | Report (Interim) |
29/08/2024 | Report (Prelim) |
27/09/2024 | Report (Annual) |
Former Company Names
- Recce Limited (RCE), 16/01/2018
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
RCE directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of RCE directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
FIL Limited | 18/09/2023 | 15,144,466 | 7.69 |
Graham John Hamilton Melrose & Olga Mary Melrose | 18/09/2023 | 37,028,311 | 18.81 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
18-09-23 | FIL Limited and the entities | 15,144,466 | -- | 7.69 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2023 | $0.625 | 30 June |
2022 | $0.890 | 30 June |
2021 | $0.930 | 30 June |
2020 | $0.670 | 30 June |
2019 | $0.215 | 28 June |
2018 | $0.190 | 29 June |
2017 | $0.205 | 28 June |
2016 | $0.250 | 28 June |

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.